The Latest Cardiac and Vascular News
Minneapolis, MN, July 11, 2017 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within the $4+ billion electrophysiology (EP) marketplace, today announced that the Company has engaged Health Research International (HRI) to compile essential market […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Following the €1.9 billion ($2.16 billion) purchase of The Spectranetics Corporation (NASDAQ:SPNC) by Royal Philips (NYSE:PHG), Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, today announced the appointment of two new members to the Company’s Board of Directors. This also follows the recent FDA market […]
By Ken Dropkiewski (ken@prime-core.com) While no hard statistics exist as to the exact number of motor vehicle accidents and concurrent heart attacks, the article 5 Facts About the Trend of Heart Attacks While Driving, makes a compelling case for why more people are suffering acute MIs while driving. – An aging population […]
Evity 8 HF-T QP Offers a Host of Functions Including LV VectorOpt, RF Telemetry, MRI AutoDetect and BIOTRONIK Home Monitoring TOKYO, Japan and BERLIN, Germany, July 10, 2017 – BIOTRONIK has announced the launch of its Evity cardiac resynchronization therapy pacemaker (CRT-P) in the Japanese market. It is the company’s highest performing […]
PARIS–(BUSINESS WIRE)–LimFlow SA today announced enrollment of the first patient in the U.S. feasibility study of the LimFlow Percutaneous Deep Vein Arterialization (pDVA) System, a novel, purely percutaneous device for the treatment of end-stage critical limb ischemia (CLI) when all other revascularization efforts have been exhausted. The first patient was treated […]
Stent coated with Viagra may help prevent blood clots By AMERICAN HEART ASSOCIATION NEWS Coating heart stents with the erectile dysfunction drug Viagra, known by the generic name sildenafil, could one day reduce blood clots and re-narrowing of arteries, according to new research. Stents prop open heart arteries to help […]
DUBLIN – July 10, 2017 – Medtronic plc (NYSE: MDT) today announced the expanded U.S. Food and Drug Administration (FDA) approval of the self-expanding CoreValve(TM) Evolut(TM) transcatheter aortic valve replacement (TAVR) platform to include patients with symptomatic severe aortic stenosis who are at an intermediate risk for open-heart surgery. With hemodynamic […]
ATLANTA, July 10, 2017 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2017 second quarter financial results will be released on Monday, July 24, 2017 after the market closes. On Tuesday, July 25, 2017 the Company will hold a teleconference call and live […]
CALGARY, July 10, 2017 /PRNewswire/ – Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) today announced that the first patient has been randomized in Taiwan in the Phase 3 BETonMACE clinical trial with lead drug apabetalone intended for high-risk patients with cardiovascular disease (“CVD”) and type 2 diabetes mellitus (“DM”). On July 8, 2015, Resverlogix and […]
WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) supplemental application to modify the primary endpoint in the Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) clinical trial from 12 months to […]
